Glaukos (GKOS) Stock Highlights

150.88 | +4.97%

2024-12-21 01:37:14

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Statistics

Range Today

142.84 151.12

Volume Today 1.05M

Range 1 Year

74.75 148.67

Volume 1 Year 145.92M

Range 3 Year

33.33 148.67

Volume 3 Year 386.93M

Range 10 Year

14.25 148.67

Volume 10 Year 1.22B

Highlights

Market Capitalization 7.82B (mid)

Floating Shares 53.34M

Current Price 150.88

Price To Earnings -47.45

Price To Revenue 21.02

Price To Book 11.68

Earnings Per Share -2.93

Payout Ratio 0%

Performance

Latest +4.97%

1 Month +4.6%

3 Months +14.78%

6 Months +33.52%

1 Year +85.77%

3 Years +252.44%

5 Years +167.04%

10 Years +418.31%

Benchmarks

Market Capitalization

16 / 44

Gross Profits

24 / 40

Total Revenue

27 / 43

Total Rank

34 / 44

Free Cashflow

41 / 44

Performance 5 years

3 / 44

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.